Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CTLT

Catalent (CTLT) Stock Price, News & Analysis

Catalent logo

About Catalent Stock (NYSE:CTLT)

Advanced Chart

Key Stats

Today's Range
$63.48
$63.48
50-Day Range
$59.66
$63.48
52-Week Range
$58.28
$63.50
Volume
N/A
Average Volume
2.08 million shs
Market Capitalization
$11.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$63.50
Consensus Rating
Hold

Company Overview

Catalent Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

CTLT MarketRank™: 

Catalent scored higher than 20% of companies evaluated by MarketBeat, and ranked 842nd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Catalent has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Catalent has received no research coverage in the past 90 days.

  • Read more about Catalent's stock forecast and price target.
  • Earnings Growth

    Earnings for Catalent are expected to grow by 73.08% in the coming year, from $0.78 to $1.35 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Catalent has a PEG Ratio of 2.69. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Catalent has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CTLT.
  • Dividend Yield

    Catalent does not currently pay a dividend.

  • Dividend Growth

    Catalent does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CTLT.
  • Search Interest

    2 people have searched for CTLT on MarketBeat in the last 30 days.
Receive CTLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Catalent and its competitors with MarketBeat's FREE daily newsletter.

CTLT Stock News Headlines

Why AMZN, GOOG, MSFT might destroy NVDA
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Lisata Therapeutics signs research license with Catalent
Catalent Announces New Board Appointments
See More Headlines

CTLT Stock Analysis - Frequently Asked Questions

Catalent, Inc. (NYSE:CTLT) posted its earnings results on Tuesday, November, 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by $0.18. Catalent's revenue was up 4.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Catalent investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Exxon Mobil (XOM).

Company Calendar

Last Earnings
11/05/2024
Today
8/03/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:CTLT
CIK
1596783
Employees
16,900
Year Founded
N/A

Price Target and Rating

High Price Target
$63.50
Low Price Target
$63.50
Potential Upside/Downside
+0.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
81.38
P/E Growth
2.69
Net Income
-$1.04 billion
Net Margins
-9.28%
Pretax Margin
-7.83%
Return on Equity
-0.66%
Return on Assets
-0.24%

Debt

Debt-to-Equity Ratio
1.38
Current Ratio
2.51
Quick Ratio
1.96

Sales & Book Value

Annual Sales
$4.38 billion
Price / Sales
2.63
Cash Flow
$2.64 per share
Price / Cash Flow
24.04
Book Value
$19.91 per share
Price / Book
3.19

Miscellaneous

Outstanding Shares
181,510,000
Free Float
180,949,000
Market Cap
$11.52 billion
Optionable
Optionable
Beta
1.15

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:CTLT) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners